(Q34817043)

English

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

Michał Tendera

4

object named as

Michal Tendera

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Roberto Ferrari

object named as

Roberto Ferrari

5

0 references

author name string

Kim Fox

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Ian Ford

2

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

P Gabriel Steg

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

BEAUTIFUL Investigators

6

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

language of work or name

0 references

publication date

29 August 2008

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

372

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

9641

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

807-816

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Predicting prognosis in stable angina--results from the Euro heart survey of stable angina: prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

One-year cardiovascular event rates in outpatients with atherothrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of asymptomatic left ventricular systolic dysfunction in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Heart rate and cardiovascular mortality: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Resting heart rate in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated heart rate: a major risk factor for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A single intravenous dose of ivabradine, a novel I(f) inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Electrophysiological Effects of a Single Intravenous Administration of Ivabradine (S 16257) in Adult Patients with Normal Baseline Electrophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The BEAUTIFUL study: randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction - baseline characteristics of the study population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimal medical therapy with or without PCI for stable coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961170-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(08)61170-8

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34817043&oldid=1650745312"